Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Male BRCA mutation carriers: clinical characteristics and cancer spectrum.

BMC cancer - 13 Feb 2018

Ibrahim Mohammed, Yadav Siddhartha, Ogunleye Foluso, Zakalik Dana

Abstract excerpt

BACKGROUND: Mutations in BRCA1 and BRCA2 (BRCA1/2) genes are associated with an increased risk of breast and ovarian cancers in women. The cancer characteristics of men with BRCA1/2 mutations are less well studied. This study describes the unique cancer characteristics of male BRCA1/2 mutation carriers at our institution. METHODS: We performed a retrospective chart review on male patients who were seen between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms, Male

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Heterozygote

Share to Kaplan-Meier Estimate

Share to Neoplasms

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 29433453
DOI: 10.1186/s12885-018-4098-y
PMCID: PMC5809938

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Male BRCA mutation carriers: clinical characteristics and cancer spectrum.PMID 29433453Read ↗

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.Semantic proximity Read ↗

A 64-Year-Old Man With Germline BRCA2-Mutated Breast Cancer: Known and Unknown Aspects of Male Breast Cancer.Semantic proximity Read ↗

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.Semantic proximity Read ↗

Male Breast Cancer: Epidemiology and Risk Factors.Semantic proximity Read ↗

Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic.Semantic proximity Read ↗

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).Semantic proximity Read ↗

Germline BRCA mutation in male carriers-ripe for precision oncology?Semantic proximity Read ↗

Male Breast Cancer: From Molecular Genetics to Clinical ManagementSemantic proximity Read ↗

Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance.Semantic proximity Read ↗

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Semantic proximity Read ↗

Counseling for male BRCA mutation carriers: a review.Semantic proximity Read ↗

Clinical Characteristics and Prognostic Implications of BRCA-associated Tumors in Males: A Pan-tumor SurveySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.